anxiety

shutterstock_177126911

Introduction

Anxiety is something we can all relate to. For the most part, anxiety represents a healthy and adaptive physiological response to feared stimuli, preparing your body to respond accordingly. Perfect if you a™re being chased by a bear. However, it can be problematic if those feared stimuli are benign, no longer present, or constitute persistent worries about the future.

At it™s most debilitating, anxiety can be classified into a range of psychiatric diagnoses. The most common of these is generalised anxiety disorder (GAD), which has an estimated lifetime prevalence in the UK of between 4-7%. GAD is characterised by a range of physical symptoms such as muscle tension, poor concentration and disturbed sleep, as well as psychological symptoms such as ongoing and uncontrollable worry. Diagnoses such as panic disorder, social anxiety disorder and phobias all feature anxiety as a primary symptom. In total, anxiety-related difficulties have been estimated to affect as many as 18% of a US-based adult population over a 12-month period.

Though previously categorised as anxiety disorders, both obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are increasingly being understood as separate diagnoses, but again with anxiety as a common symptom.

What we know already

People with long-term physical health conditions are more prone to experience anxiety as a result. For example, it is estimated that people with Chronic Obstructive Pulmonary Disease (COPD) are up to 10 times more likely to receive a diagnosis of panic disorder than the general population. This, in turn, has considerable implications on healthcare expenditure.

Psychological treatments such a cognitive-behavioural therapy (CBT) have been widely researched and shown to be effective across a range of anxiety disorders. In the case of specific phobias, these techniques can elicit significant improvement in just one session. However, improvement rates are lower across other anxiety disorders.

In England, the National Institute for Health and Care Excellence (NICE) recommends CBT as the first line treatment of anxiety disorders. Pharmacotherapy, such as Sertraline, can also be beneficial, and is recommended as an adjunct to CBT where the person’™s difficulties are more severe.

Areas of uncertainty

Anxiety has been conceptualised in many ways, which in many ways have shaped the range of treatments available. This proliferation of cognitive, developmental, information-processing, neurochemical and other models of understanding anxiety can create a confusing picture. Similarly, whilst there is a clear hereditary component to anxiety, the precise nature is not yet clear.

Whilst psychological and pharmacological treatments can be effective for many, there is still work to be done in identifying the mechanisms of change and improving outcomes.

What’s in the pipeline?

Historically, research into anxiety disorders focused more heavily on adult populations. However, with the recent emergence of disciplines such as paediatric psychology, there is a greater emphasis on tackling anxiety difficulties at a younger age.

As our understanding of genetics improves, it is likely that we will discover more about the role of heritability in anxiety.

Perhaps, most importantly, given the effectiveness of treatments for anxiety, we should aim to reduce stigma and other barriers to access, to enable earlier intervention and better recovery.

References

Antony, M. M., and Stein, M. B. (2009). Oxford handbook of anxiety and related disorders. Oxford University Press. [Publisher]

Hoge, E. A., Ivkovic, A. and Fricchione, G. L. (2012). Generalized anxiety disorder: diagnosis and treatment. BMJ, 345. [Abstract]

Kesller, R. C., Ciu, W. T., Deler, O. and Walters, E. E. (2005). Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [PDF]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our anxiety Blogs

CBT for anxiety: new meta-analysis confirms significant improvements to target symptoms

CBT plus taper is effective at reducing benzodiazepine use in the short term (3 months) but this effect is not sustained at 6 months.

Inês Pote summarises a recent meta-analysis of randomised placebo-controlled trials of cognitive behavioural therapy for anxiety and related disorders.

[read the full story...]

Poorer cardiovascular screening, diagnosis and management if you have a mental illness

nick-fewings-532590-unsplash

Joanne Wallace summarises a systematic review that highlights disparities in the management of cardiovascular risk factors in people with mental illness.

[read the full story...]

The genetics of depression (and anxiety!)

kristina-tripkovic-649227-unsplash

Thalia Eley shares her thoughts on a recent Nature genome-wide association study of depression phenotypes in the UK Biobank, which uses different definitions of depression to provide more tractable targets for future genetic studies.

[read the full story...]

CBT may help to improve emotion regulation in children with autism

hermes-rivera-285867-unsplash

James Cusack from Autistica writes his debut elf blog on a new RCT of CBT to improve emotion regulation in children with autism, published recently in the Journal of Child Psychology and Psychiatry.

[read the full story...]

Dental anxiety: Non-pharmacological treatment may be beneficial

Should we be paying more attention to anxiety in people with psychosis?

This review of non-pharmacological intervention to reduce mental distress, pain, and analgesic use in adults undergoing dental treatment included 29 RCTs. The findings suggest positive benefits for the interventions examined with no significant differences between the various interventions.

[read the full story...]

Preventing anxiety with psychological and educational interventions

mark-skeet-531298

Inês Pote publishes her debut elf blog about a recent systematic review on the effectiveness of psychological and/or educational interventions in the prevention of anxiety.

[read the full story...]

Prevention and early intervention for youth mental illness: how should we focus our limited resources? #MQScienceMeeting

craig-whitehead-431483

André Tomlin presents a summary of all the evidence we have highlighted over the last 3 years relating to prevention and early intervention for mental illness in young people.

This blog accompanies the #MQScienceMeeting coverage this week, which you can follow on Twitter.

[read the full story...]

The Origins of Happiness: can we predict life satisfaction?

the-origins-of-happiness

Paul Ramchandani considers the methods, findings and implications of a new book by Andrew E. Clark, Sarah Fleche, Richard Layard, Nattavudh Powdthavee and George Ward, entitled: ‘The Origins of Happiness: The science of well-being over the life course’.

[read the full story...]

Common mental health problems and psychotic experiences in IAPT

Psychodynamic therapy draws on theories and practices of analytical psychology and psychoanalysis.

Mark Smith reviews a recent service evaluation looking at common mental health conditions and psychotic experiences occurring at the same time in IAPT services.

[read the full story...]

Bullying in childhood: cause or consequence of mental health problems? #AntiBullyingWeek

Victims who reported being bullied on numerous occasions had higher rates of psychosis

Stefan Brugger publishes his debut elf blog on a recent study, which looks at the role of vulnerability and resilience in relation to mental health and bullying in childhood.

Today marks the start of #AntiBullyingWeek, so look out for lots of activity around this theme on social media.

[read the full story...]